Cargando…

Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies’ professionals in the European Economic Area

BACKGROUND: The Falsified Medicines Directive (FMD) is a response of the European Union to the increasing number of falsified medicines present in the legal supply chain within the Member States of the community. Effective implementation of the new regulations will depend on the effective cooperatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	WŁodarczak, Urszula, Swieczkowski, Damian, Religioni, Urszula, Jaguszewski, Milosz, Krysinski, Jerzy, Merks, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741995/ https://www.ncbi.nlm.nih.gov/pubmed/29317918 http://dx.doi.org/10.18549/PharmPract.2017.04.1031

Ejemplares similares

Patient counselling service with the use of pictograms as the example of pharmacist intervention to improving compliance and medicine safety
por: Merks, Piotr, et al.
Publicado: (2021)

Falsified Drugs in the Opinion of Patients Diagnosed with Cardiovascular Diseases—Nationwide and Cross-Sectional Study on the Example of EU-Member Country
por: Świeczkowski, Damian, et al.
Publicado: (2021)

The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists
por: Merks, Piotr, et al.
Publicado: (2018)

Hospital Audit as a Useful Tool in the Process of Introducing Falsified Medicines Directive (FMD) into Hospital Pharmacy Settings—A Pilot Study
por: Religioni, Urszula, et al.
Publicado: (2017)

Quality of Pharmaceutical Services in Independent Pharmacies and Pharmacy Chains in Poland from the Patient Perspective
por: Bratkowska, Karolina, et al.
Publicado: (2020)

Access to Medicines via Non-Pharmacy Outlets in European Countries—A Review of Regulations and the Influence on the Self-Medication Phenomenon
por: Oleszkiewicz, Patrycja, et al.
Publicado: (2021)

The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review
por: Świeczkowski, Damian, et al.
Publicado: (2022)

Patients’ perception of pharmaceutical services available in a community pharmacy among patients living in a rural area of the United Kingdom
por: Merks, Piotr, et al.
Publicado: (2016)

The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
por: Merks, Piotr, et al.
Publicado: (2018)

Pilot Implementation of Falsified Medicines Directive in Hospital Pharmacy to Develop Best Practices for Medicine Decommissioning Process
por: Merks, Piotr, et al.
Publicado: (2020)

Development of Pharmacy Practice in European Countries—The Polish Perspective
por: Świeczkowski, Damian, et al.
Publicado: (2017)

The Awareness of Risks Associated with OTC Drugs Available in Non-Pharmacy Outlets among Polish Patients—A Cross-Sectional Study
por: Dulęba, Jacek, et al.
Publicado: (2021)

Patient satisfaction survey of the “Healthy Heart” pharmaceutical care service – evaluation of pharmacy labelling with pharmaceutical pictograms
por: Merks, Piotr, et al.
Publicado: (2023)

Evaluation of a pharmacist-led intervention to improve medication adherence in patients initiating dabigatran treatment: a comparison with standard pharmacy practice in Poland
por: Merks, Piotr, et al.
Publicado: (2022)

Patients’ Perspective And Usefulness Of Pictograms In Short-Term Antibiotic Therapy – Multicenter, Randomized Trial
por: Merks, Piotr, et al.
Publicado: (2019)

Public Perception of Pharmacists in Poland
por: Andrzejewska, Maja, et al.
Publicado: (2022)

The Quality and Reliability of Information in the Summaries of Product Characteristics
por: Drelich, Ewelina, et al.
Publicado: (2022)

Falsified Medicines Directive in a Secondary Care Environment—Impact on Supply Chain
por: Merks, Piotr, et al.
Publicado: (2022)

Community Pharmacies in Poland—The Journey from a Deregulated to a Strictly Regulated Market
por: Wiśniewski, Marcin, et al.
Publicado: (2020)

Evaluation of the Community Pharmacy Comorbidities Screening Service on Patients with Chronic Diseases
por: Lewicki, Jędrzej, et al.
Publicado: (2021)

Readiness and Willingness to Provide Immunization Services after Pilot Vaccination Training: A Survey among Community Pharmacists Trained and Not Trained in Immunization during the COVID-19 Pandemic in Poland
por: Merks, Piotr, et al.
Publicado: (2021)

Challenges for Polish Community Pharmacists in Provision of Services to Immigrants and Non-Polish-Speakers in 2018
por: Plombon, Marcin, et al.
Publicado: (2021)

Medication Adherence and the Role of Pictograms in Medication Counselling of Chronic Patients: a Review
por: Merks, Piotr, et al.
Publicado: (2021)

Assessment of Awareness and Knowledge about Osteoporosis in Relation to Health Prevention among Patients Treated in Osteoporosis Clinics
por: Barańska, Agnieszka, et al.
Publicado: (2023)

Deploying and Maintaining Standards of New Pharmacy Services Provision in Poland-Introducing the National Pharmacist Competencies Assessment Tool: Pre-Registration Exam–Results of the Pilot Project
por: Merks, Piotr, et al.
Publicado: (2022)

The legal extension of the role of pharmacists in light of the COVID-19 global pandemic
por: Merks, Piotr, et al.
Publicado: (2021)

The economic impact of substandard and falsified antimalarial medications in Nigeria
por: Beargie, Sarah M., et al.
Publicado: (2019)

Long-Term Impairment in Activities of Daily Living Following COVID-19 in Residents of Long-Term Care Facilities
por: Goździewicz, Łukasz, et al.
Publicado: (2023)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021)

Respecting the Patient’s Right to Information in Hospital Wards in Poland – Socio-Economic Determinants of Patients’ Opinions
por: Borowska, Mariola, et al.
Publicado: (2023)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study
por: Masoumi, Mohammadreza, et al.
Publicado: (2019)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention
por: Sylim, Patrick, et al.
Publicado: (2018)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Drug Interactions Affecting Kidney Function: Beware of Health Threats from Triple Whammy
por: Harężlak, Tomasz, et al.
Publicado: (2021)

Assessment of Pharmacists’ Willingness to Conduct Medication Use Reviews in Poland
por: Merks, Piotr, et al.
Publicado: (2022)

Coping Strategies Preferred by Patients Treated for Osteoporosis and Analysis of the Difficulties Resulting from the Disease
por: Barańska, Agnieszka, et al.
Publicado: (2022)

Assessment of the Level of Satisfaction with Medical Care of Patients Treated in Osteoporosis Clinics as an Indicator of the Quality of Medical Care
por: Barańska, Agnieszka, et al.
Publicado: (2022)

Falsifying the Dehumanization Hypothesis
por: Over, Harriet
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ln0glugbc8nulon3nqqs9ktp28